Palisade Bio to Participate in the Virtual Investor Lunch Break Event
11 Avril 2024 - 3:15PM
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”
or the “Company”), a biopharmaceutical company focused on
developing and advancing novel therapeutics for patients living
with autoimmune, inflammatory, and fibrotic diseases, today
announced that it will present at the Virtual Investor Lunch Break
Featuring Palisade Bio event on Tuesday, April 16, 2024 at 12:00 PM
ET.
As part of the event, J.D. Finley, Chief
Executive Officer and Dr. Mitch Jones, Chief Medical Officer of
Palisade Bio, will provide a corporate overview, business outlook,
and discuss the Palisade Bio opportunity.
A live video webcast of the presentation will be
available on the Events page of the Investors section of the
Company’s website (www.palisadebio.com). A webcast replay will be
available two hours following the live presentation and will be
accessible for 90 days.
About Palisade
Bio Palisade Bio is a biopharmaceutical company
focused on developing and advancing novel therapeutics for patients
living with autoimmune, inflammatory, and fibrotic diseases. The
Company believes that by using a targeted approach with its novel
therapeutics it will transform the treatment landscape. For more
information, please go to www.palisadebio.com.
Investor Relations ContactJTC
Team, LLCJenene Thomas 833-475-8247PALI@jtcir.com
Palisade Bio (NASDAQ:PALI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Palisade Bio (NASDAQ:PALI)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024